|
First-Time Generics - February 2008
| |
Generic Drug Name |
Generic Manufacturer |
Brand Name |
Approval Date |
| 1 |
CEFUROXIME AXETIL FOR ORAL SOLUTION, USP 125 MG/5 ML 250 MG/5 ML |
RANBAXY PHARMACEUTICALS, INC. |
CEFTIN FOR ORAL SUSPENSION |
2/5/2008 |
| 2 |
FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE 10 MG, 800 MG, 165 MG |
PERRIGO R&D COMPANY |
PEPCID COMPLETE |
2/6/2008 |
| 3 |
ALENDRONATE SODIUM TABLETS USP, 5 MG (BASE), 10 MG (BASE), AND 40 MG (BASE) FOR ONCE-DAILY DOSING; AND 35 MG (BASE) AND 70 MG (BASE) FOR ONCE-WEEKLY DOSING |
TEVA PHARMACEUTICALS USA |
FOSAMAX TABLETS |
2/6/2008 |
| 4 |
ALENDRONATE SODIUM TABLETS USP, 70 MG (ONCE WEEKLY) |
BARR LABORATORIES, INC. |
FOSAMAX TABLETS |
2/6/2008 |
| 5 |
PRAMIPEXOLE DIHYDROCHLORIDE TABLETS, 0.125 MG, 0.25 MG, 0.5 MG, 1 MG, AND 1.5 MG |
BARR LABORATORIES, INC. |
MIRAPEX TABLETS |
2/19/2008 |
| 6 |
IRINOTECAN HYDROCHLORIDE INJECTION, 20 MG/ML; PACKAGED IN 40 MG/2 ML AND 100 MG/5 ML SINGLE-USE VIALS |
WATSON LABORATORIES, INC. |
CAMPTOSAR INJECTION |
2/20/2008 |
| 7 |
CETIRIZINE HCL& PSEUDOEPHEDRINE HCL EXTENDED-RELEASE TABLETS 5 MG/120 MG |
TEVA PHARMACEUTICALS USA |
ZYRTEC-D EXTENDED-RELEASE TABLETS |
2/25/2008 |
| 8 |
CALCIUM ACETATE CAPSULES, 667 MG (EQUIVALENT TO 169 MG CALCIUM) |
ROXANE LABORATORIES, INC. |
PHOSLO GELCAPS |
2/26/2008 |
| 9 |
GRANISETRON HYDROCHLORIDE ORAL SOLUTION, 2 MG (BASE)/10 ML |
CYPRESS PHARMACEUTICAL, INC. |
KYTRIL ORAL SOLUTION, 2 MG/10 ML |
2/28/20 |
 Back to Top 
Back to Approvals
Date created: March 12, 2008 |
|
